Thryve, a B2B health data integration and analytics company headquartered in Berlin, has successfully closed a €4 million Series A funding round. This significant investment will fuel the company’s ambitious international expansion plans and strengthen its wearable integration capabilities for automated prevention and treatment. The funding round was led by Capricorn Partners from Belgium, with additional support from IBB Ventures, CRB Health Tech from Spain, and Carma Fund from Germany.
Thryve’s integrated API is at the forefront of health data integration, enabling health services around the world to continuously monitor and interpret an individual’s health status through data collected from hundreds of health trackers. This technology is a critical component in providing preventive and automated care that is accessible anywhere, anytime.
Thryve’s technology has already been widely adopted across Europe, with over 50 million people accessing the solution through their health insurers for early prevention. Leading companies such as AOK in Germany and Sanitas in Spain rely on Thryve’s technology. Digital therapeutics such as the leading DiGA-certified Sidekick Rx use Thryve’s data integration to enhance personalization and proactive care, and in particular to treat conditions such as obesity through its product Zanadio.
As industrialized nations grapple with shrinking workforces and aging populations, demand for healthcare far outstrips available capacity. In Germany alone, more than 30% of physicians are set to retire in the next five years, further straining the healthcare system. Digital health services that provide faster, more proactive care are increasingly sought after by regulators, payers, and consumers alike. With the market growing by more than 20% annually and one in two people now using a health tracker, Thryve’s technology is instrumental in preventing disease through early detection and ensuring ongoing access to actionable healthcare insights.
Thryve is dedicated to advancing early disease detection and treatment through fully automated home-based solutions based on health trackers. The newly acquired capital will allow the company to expand its customer base, which currently spans over 20 countries, and to enhance its analytics and preventive health capabilities. Thryve already offers assessments in areas such as mental, cardiovascular, and metabolic health, and plans to expand the scope of marker applications and allow customers to run algorithms within its engine.
Antoine D´Hollander, Investment Director at Capricorn Partners, commented on the investment: “This new funding aligns with our strategy to leverage real-world data for personalized prevention and treatment. We are excited about Thryve’s solution, which integrates data from thousands of wearable devices and health apps to create a cost-effective healthcare ecosystem that facilitates personalized interventions and effective monitoring.”
Friedrich Lammel, CEO of Thryve, echoes this passion. “Healthcare is undergoing a transformational transformation. I am confident that our engine will make millions of hospital visits obsolete and help people live 20 years longer and healthier lives in the next five years. We are excited to partner with Europe’s leading health fund on this mission and look forward to accelerating its growth.”